摘要
炎症性肠病(inflammatory bowel disease,IBD)是一种慢性非特异性肠道炎症性疾病,其发病机制复杂。IBD患者肠道菌群的组成与结构发生明显变化即肠道菌群失调。肠道屏障功能对维持人体肠道功能稳态发挥着重要调节作用。研究表明,在IBD中存在肠道屏障功能受损、肠道通透性增加。肠道菌群失调导致肠道屏障功能受损,从而破坏人体正常的肠道稳态功能,加重IBD的进展。本文将对肠道菌群与肠道屏障功能之间的互作在IBD发生发展及治疗中的应用进行阐述。这将为IBD的防治提供理论基础和新思路。
Inflammatory bowel disease(IBD)is a chronic nonspecific intestinal inflammatory disease with complex pathogenesis.The composition and structure of gut microbiota in patients with IBD are significantly changed,that is,dysbacteriosis.Intestinal barrier function plays an important regulatory role in maintaining intestinal homeostasis.Studies have shown impaired intestinal barrier function and increased intestinal permeability in IBD.The imbalance of gut microbiota leads to impaired intestinal barrier function,which destroys the normal intestinal homeostasis and aggravates the progression of the disease.The interaction between gut microbiota and intestinal barrier function and its application in the development and treatment of IBD will be described in this paper.This will provide theoretical basis and new ideas for the prevention and treatment of IBD.
作者
李瑶
黄金莉
黄娟
李华军
LI Yao;HUANG Jinli;HUANG Juan;LI Huajun(Department of Microecology,Dalian Medical University,Dalian 116044,China)
出处
《胃肠病学和肝病学杂志》
CAS
2021年第1期10-15,共6页
Chinese Journal of Gastroenterology and Hepatology
关键词
肠道屏障
肠道菌群失调
炎症性肠病
生物拮抗
免疫调节
SCFA
Intestinal barrier
Dysbacteriosis
Inflammatory bowel disease
Colonization resistance
Immune regulation
SCFA